Publication | Open Access

Cetuximab plus carboplatin and paclitaxel with or without bevacizumab versus carboplatin and paclitaxel with or without bevacizumab in advanced NSCLC (SWOG S0819): a randomised, phase 3 study

Advanced NsclcSwog S0819OncologyMedicineBevacizumab Versus CarboplatinClinical TrialsPharmacotherapyAnti-cancer AgentCancer TreatmentPharmacologyLung Cancer